Pregnancy, patient tailored care, maternity care, antenatal care, maternal empowerment
Conditions
Interventions
The study is embedded in the Healthy Pregnancy 4 All- 2 program (HP4All-2), a nationwide program in the Netherlands that aims to reduce health inequalities and improve the care for young children and
a Dutch screen-and-advice tool developed and validated for routine us in antenatal obstetric care, complemented with an adjusted form of the Maternal Empowerment Questionnaire (MEQ).
The personalise
Sponsors
The research team has received funding from the Ministry of Health, Welfare and Sports in order to execute the Healthy Pregnancy 4 All study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of a manuscript.
Eligibility
Inclusion criteria
Inclusion criteria: Support for the study in a maternity care organisation was sought from senior staff, and executives with responsibility for clinical quality and safety. Maternity care organisations were required to demonstrate sufficient capacity to maximise their engagement with the study. The studied intervention requires an interview scheduled at home for each client. All pregnant women cared for by participating maternity care organisations, which have a scheduled home visit during pregnancy, within the selected postal codes of the participating municipalities, are invited to take part in the trial.
Exclusion criteria
Exclusion criteria: Exclusion criteria are not having a planned home visit during pregnancy and inadequate knowledge of the Dutch language, English language, Polish language, or Turkish language.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the mean overall maternal empowerment score (range 1-4), assessed using the Maternal Empowerment Questionnaire (MEQ) between day 7 and 14 postpartum. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are: maternal physical health assessed by The Short Form Health Survey (SF-36) between day seven and 14 postpartum, the Edinburgh Postnatal Depression Scale (EPDS) assessed six to 12 weeks postpartum, the initiation of breastfeeding (no/yes), the prolongation of breastfeeding (categorical: continued, added formula feeding, stopped) measured at two separate time point; first between day seven to 14 postpartum, and second between six to twelve weeks postpartum, parental compliance with neonatal vitamin-K supplementation when breastfeeding (no/yes), parental compliance with neonatal safe sleep practices (no/yes), maternal smoking behaviour postpartum (no/yes), maternal alcohol use postpartum (no/yes), and additional maternal and neonatal health care utilization in the first three months postpartum (no/yes) assessed between six to 12 weeks postpartum. In addition, we will assess implementation of our study protocol via questionnaires addressed to managers of maternity care organisations and to local researchers. | — |
Contacts
Public ContactJ Lagendijk
PO Box 2040
Outcome results
None listed